Show simple item record

dc.contributor.authorStørdal, Ketil
dc.contributor.authorMcArdle, Harry J.
dc.contributor.authorHayes, Helen
dc.contributor.authorTapia, German
dc.contributor.authorViken, Marte K.
dc.contributor.authorLund-Blix, Nicolai A.
dc.contributor.authorHaugen, Margaretha
dc.contributor.authorJoner, Geir
dc.contributor.authorSkrivarhaug, Torild
dc.contributor.authorMårild, Karl
dc.contributor.authorNjølstad, Pål R.
dc.contributor.authorEggesbø, Merete
dc.contributor.authorMandal, Siddhartha
dc.contributor.authorPage, Christian M.
dc.contributor.authorLondon, Stephanie J.
dc.contributor.authorLie, Benedicte A.
dc.contributor.authorStene, Lars C.
dc.date.accessioned2018-07-25T23:06:48Z
dc.date.available2018-07-25T23:06:48Z
dc.date.issued2018-06-13
dc.identifier.citationStørdal , K , McArdle , H J , Hayes , H , Tapia , G , Viken , M K , Lund-Blix , N A , Haugen , M , Joner , G , Skrivarhaug , T , Mårild , K , Njølstad , P R , Eggesbø , M , Mandal , S , Page , C M , London , S J , Lie , B A & Stene , L C 2018 , ' Prenatal iron exposure and childhood type 1 diabetes ' Scientific Reports , vol. 8 , 9067 . https://doi.org/10.1038/s41598-018-27391-4en
dc.identifier.issn2045-2322
dc.identifier.otherPURE: 129971224
dc.identifier.otherPURE UUID: f8dab90b-8586-442f-a702-a8ed684fe87e
dc.identifier.otherScopus: 85048503012
dc.identifier.otherORCID: /0000-0001-5186-2696/work/47011435
dc.identifier.urihttp://hdl.handle.net/2164/10807
dc.identifier.urihttp://www.scopus.com/inward/record.url?scp=85048503012&partnerID=8YFLogxKen
dc.descriptionAcknowledgements: We are grateful to all the participating families in Norway who take part in this on-going cohort study. We thank Dr. Maria Vistnes at Diakonhjemmet Hospital, Oslo, Norway for help with cytokine assays, PM Ueland and Ø Midttun at BEVITAL, Bergen, Norway, for neopterin and KTR assay, and Kathleen Gillespie at Bristol University, UK for confirmatory HLA genotyping. The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research, NIH/NIEHS (contract no N01-ES-75558), NIH/NINDS (grant no. 1 UO1 NS 047537-01 and grant no. 2 UO1 NS 047537-06A1). The sub-study was funded by a research grant from the Research Council of Norway. The Norwegian Childhood Diabetes Registry is financed by the South-Eastern Norway Regional Health Authority. Dr London was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences. Dr Størdal was supported by an unrestricted grant from Oak Foundation, Geneva, Switzerland.en
dc.language.isoeng
dc.relation.ispartofScientific Reportsen
dc.rightsThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.en
dc.subjectR Medicineen
dc.subjectGeneralen
dc.subject.lccRen
dc.titlePrenatal iron exposure and childhood type 1 diabetesen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen, Rowett Instituteen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1038/s41598-018-27391-4


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record